Skip to content
triangle-white-good

FEATURED BLOG ARTICLE

ASH 2019: Great Innovations To Help Researchers Help Patients

By Joyce Emerson Cleary, MSN, MBA

READ MORE
Download and learn how our intelligence and technology is powering better clinical trials for all.

FEATURED BLOG ARTICLE

ASH 2019: Great Innovations To Help Researchers Help Patients

READ MORE
Download and learn how our intelligence and technology is powering better clinical trials for all.

December 16, 2019

A New Beginning: RWD and Non–Small-Cell Lung Cancer Patients

What if real-world data (RWD) sources can increase the speed of getting therapies to market? Instead of waiting five years for a clinical trial to be designed, enrolled, and completed … What if we could do it in 1/5 of the time?  That journey is underway.  Many organizations—academia, public and private companies, health policy groups and the FDA—are working to establish best practices for generating and evaluating RWD. […]

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.

October 12, 2019

What We Saw at DPharm: Disruptive Innovation—Moving Toward Patient Centricity

“Too much cost. Too much time. Too much uncertainty,” were themes heard over and over at 2019’s DPharm: Disruptive Innovations Conference in Boston. The two-day gathering highlights the promises and challenges of bringing innovation to drug development, so therapeutics get to patients faster. We also heard that Pharma has had enough. And it’s time to […]

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.

October 2, 2019

Modernizing Oncology Clinical Trials: Get the Right Data First – Then Use Technology

Only 13.8% of drug development programs lead to FDA approval, according to a 2018 MIT Sloan School of Management study. More than eight out of ten clinical trials don’t finish on time – even with technology designed to help researchers plan and conduct effective clinical trials. Many studies with complex criteria, especially in oncology, continue […]

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.

August 20, 2019

Inteliquet Spotlight: Joyce Emerson Cleary, MSN, MBA

Joy is Inteliquet’s Vice President of Life Sciences and Strategic Account Management. Her career began as an oncology nurse and then she moved to implementing multiple phase I-III investigational clinical trials of various biologics and chemotherapeutics, including one of the first bone marrow transplant clinical research programs. From there, she went on to head up […]

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.

July 11, 2019

NLP Technology Can Improve Patient Forecasting in Clinical Trial Feasibility

Patient forecasting needs innovation since traditional methods, such as using best guesses and estimates from investigators, consistently fail sponsors and CROs. In fact, nearly 80% of clinical trials don’t meet enrollment timelines. Such challenges occur in part because sponsors and CROs lack access to the kind of information that can better inform which patients may be viable candidates for complex oncology clinical trials.

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.

June 25, 2019

Inteliquet & Clinical Trial Success: “Screen Every Patient, Every Night, for Every Trial.”

When asked the question of how Inteliquet can help clinical trials succeed, CEO Carla Balch did not hesitate. Carla said Inteliquet, as a technology innovator, is capable of “Screening Every Patient, Every Night, for Every Trial.” She also noted that the more patients you can screen for clinical trials, the more patients can be approached. […]

Read More
Download and learn how our intelligence and technology is powering better clinical trials for all.